2012
DOI: 10.1586/eem.12.7
|View full text |Cite
|
Sign up to set email alerts
|

Gestational diabetes: screening for all, which test and which treatment?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2013
2013
2019
2019

Publication Types

Select...
2
1
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 17 publications
0
1
0
Order By: Relevance
“…It is expected that the global prevalence of GDM, which is currently from <1 to 28%, will continue to grow. It has become clear that there is a large gap between the enormous global number of pregnant women with GDM and the small proportion of women who were diagnosed and left on their own (19). Although the risk of AO associated with GDM is well known, the impact on the health of mothers and neonates is less well known regarding borderline GDM (GIGT), which is characterized by values between NTG and GDM.…”
Section: Discussionmentioning
confidence: 99%
“…It is expected that the global prevalence of GDM, which is currently from <1 to 28%, will continue to grow. It has become clear that there is a large gap between the enormous global number of pregnant women with GDM and the small proportion of women who were diagnosed and left on their own (19). Although the risk of AO associated with GDM is well known, the impact on the health of mothers and neonates is less well known regarding borderline GDM (GIGT), which is characterized by values between NTG and GDM.…”
Section: Discussionmentioning
confidence: 99%